PAF-metabolic enzymes and PAF-like activity in L. infantum and L. major promastigotes

European Journal of Inflammation

Volumn 9, Issue 3, 2011, Pages 231-239

  Chatzovoulos, P ^a   Tsoupras, A B ^a   Samiotaki, M ^b   Panayotou, G ^b   Demopoulos, C A ^a   Dotsika, E ^c  

^a UNIVERSITY OF ATHENS   (Greece)

^b BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING   (Greece)

^c HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

Infection; Inflammation; Leishmania infantum; Leishmania major; Leismaniasis; Lyso PAF AT; PAF CPT; Platelet activating factor (PAF)

Indexed keywords

ACYLTRANSFERASE; CHOLINEPHOSPHOTRANSFERASE; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; ARTICLE; BIOSYNTHESIS; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME MECHANISM; HOMOGENATE; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; LEISHMANIASIS; NONHUMAN; PROMASTIGOTE; PROTEIN FUNCTION; SPECIES DIFFERENCE; THROMBOCYTE AGGREGATION;

EID: 84858692305     PISSN: 1721727X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1721727X1100900303     Document Type: Article

References (27)

1. World Health Organization. Control of the leishmaniases. Report of a WHO expert committee. World Health Organ Tech Rep Ser 2010; 949:1-186
2. Alvar J, Aparicio P, Aseffa A, et al. The relationship between leishmaniasis and AIDS: the second 10 years. J Clin Microbiol Rev 2008; 21:334-59. (Pubitemid 351555511)
3. Matlashewski G, Arana B, Kroeger A, et al. Visceral leishmaniasis: elimination with existing interventions. Lancet Infect Dis 2011; 11:322-25.
4. Croft SL, Snowdon D, Yardley V. The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei. J Antimicrob Chemother 1996; 38:1041-47. (Pubitemid 27073283)
5. Danker K, Reutter W, Semini G. Glycosidated phospholipids: uncoupling of signalling pathways at the plasma membrane. Br J Pharmacol 2010; 160:36-47.
6. Prescott SM, Zimmerman GA, Stafforini DM, McIntyre TM. Platelet-activating factor and related lipid mediators. Annu Rev Biochem 2000; 69:419-45.
7. Demopoulos CA, Pinckard RN, Hanahan DJ. Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J Biol Chem 1979; 254:9355-58. (Pubitemid 10248704)
8. Nomikos T, Fragopoulou E, Antonopoulou S. Food ingredients and lipid mediators. Curr Nutr Food Sci 2007; 3:255-76. (Pubitemid 350130928)
9. Kulikov VI, Muzya GI. Ether lipids and platelet-activating factor: evolution and cellular function. Biochemistry (Mosc) 1997; 62:1103-8. (Pubitemid 127595471)
10. Rodrigues CO, Dutra PM, Souto-Padrón T, Cordeiro RS, Lopes AH. Effect of platelet-activating factor on cell differentiation of Trypanosoma cruzi. Biochem Biophys Res Commun 1996; 223:735-40. (Pubitemid 26246143)
11. Denizot Y, Dassa E, Thomas Y, Benveniste J. Production of PAF-acether by various bacterial strains. Gastroenterol Clin Biol 1990; 14:681-2. (Pubitemid 20343031)
12. Lonardoni MV, Russo M, Jancar S. Essential role of platelet-activating factor in control of Leishmania (Leishmania) amazonensis infection. Infect Immun 2000; 68:6355-61.
13. Rosa MdSS, Vieira RB, Pereira AF, Dutra PML, Lopes AHCS. Platelet-Activating Factor (PAF) modulates peritoneal mouse macrophage infection by Leishmania amazonensis. Curr Microbiol 2001; 43:33-37.
14. Dutra PM, Vieira DP, Meyer-Fernandes JR, Silva-Neto MA, Lopes AH. Stimulation of Leishmania tropica protein kinase CK2 activities by platelet-activating factor (PAF). Acta Trop 2009; 111:247-54.
15. Santiago HC, Braga Pires MF, Souza DG, Roffe E, Cortes DF, Tafuri WL, Teixeira MM, Vieira LQ. Platelet activating factor receptor-deficient mice present delayed interferon-gamma upregulation and high susceptibility to Leishmania amazonensis infection. Microbes Infect 2006; 8:2569-77. (Pubitemid 44612727)
16. Tsoupras AB, Chini M, Tsogas N, et al. Anti-platelet-activating factor effects of highly active antiretroviral therapy (HAART): a new insight in the drug therapy of HIV infection? AIDS Res Hum Retroviruses 2008; 24:1079-86.
17. Frank C, Hadziantoniou M, Pratlong F, Rioux JA, Volter W. Biochemical identification of human leishmania strains isolated in Greece. Bull Soc Franc Parasitai 1990; 8:239-41.
18. Papadopoulou G, Karagouni E, Dotsika E. ISCOMs vaccine against experimental leishmaniasis. Vaccine 1998; 16:885-92. (Pubitemid 28275997)
19. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37:911-7.
20. McManus LM, Hanahan DJ, Demopoulos CA, Pinckard RN. Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit. J Immunol 1980; 124:2919-24. (Pubitemid 10116077)
21. Tsoupras AB, Demopoulos CA, Pappas KM. Platelet activating factor detection, metabolism and inhibitors in the ethanologenic bacterium Zymomonas mobilis. Eur J Lipd Sc & Techn 2011; Article in print.
22. Tsoupras, AB, Fragopoulou E, Nomikos T, Iatrou C, Antonopoulou S, Demopoulos CA. Characterization of the de novo biosynthetic enzyme of platelet activating factor, DDT-insensitive cholinephosph otransferase, of human mesangial cells. Mediators Inflamm 2007; 2007:27683.
23. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-54.
24. Gomes MT, Monteiro RQ, Grillo LA, et al. Platelet-activating factor-like activity isolated from Trypanosoma cruzi. Int J Parasitol 2006; 36:165-73. (Pubitemid 43208982)
25. Tsoupras AB, Iatrou C, Frangia C, Demopoulos CA. The implication of platelet activating factor in cancer growth and metastasis: potent beneficial role of PAF-inhibitors and antioxidants. Infect Disord Drug Targets 2009; 9:390-99.
26. Gimenez R, Aguilar J. Cytidine (5-) diphosphocholine-induced decrease in cerebral platelet activating factor is due to inactivation of its synthesizing enzyme cholinephosphotransferase in aged rats. Neurosc Let 2001; 299:209-12. (Pubitemid 32124848)
27. Tsoupras AB, Chini M, Mangafas N, et al. Platelet-activating factor and its basic metabolic enzymes in blood of naive HIV-infected patients. Angiology 2011; Epub ahead of print.